[
    [
        {
            "time": "",
            "original_text": "复宏汉霖汉利康新增外推适应症获NMPA受理，惠及患者群体进一步扩大",
            "features": {
                "keywords": [
                    "复宏汉霖",
                    "汉利康",
                    "新增适应症",
                    "NMPA受理",
                    "患者群体"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "复宏汉霖汉利康新增外推适应症获NMPA受理，惠及患者群体进一步扩大",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "A股创业药创新高，海内外原研药差距有多大",
            "features": {
                "keywords": [
                    "A股",
                    "创业药",
                    "创新高",
                    "原研药",
                    "差距"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "资本市场"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股创业药创新高，海内外原研药差距有多大",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【民生医药|周报】关注“补短板”，持续推荐API、CXO 和医疗器械板块",
            "features": {
                "keywords": [
                    "民生医药",
                    "周报",
                    "补短板",
                    "API",
                    "CXO",
                    "医疗器械"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【民生医药|周报】关注“补短板”，持续推荐API、CXO 和医疗器械板块",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]